Reach out to us: hello@wundrsight.com
Corp. Address: BHive HSR, AKR Tech Park Block A, 7th Mile Hosur Rd, Krishna Reddy Industrial Area, Bengaluru, Kudlu Gate, Karnataka 560068
Copyright © 2024. All rights reserved.
Wundrsight Private Limited.
Wundrsight raises USD 400K in Seed Round led by Inflection Point Ventures, Social Alpha and angel investors
12 September, 2024
Dear Wundrsight Community,
It is with great excitement that I announce our successful early-stage fundraise of USD 400,000, led by Inflection Point Ventures, Social Alpha, and a select group of angel investors who share our vision of transforming mental health care. This milestone marks an important step in our journey as we continue to innovate and build solutions that redefine how mental and behavioral healthcare is delivered.
We are fortunate to have Inflection Point Ventures and Social Alpha as key investors supporting our mission. Inflection Point Ventures has a track record of backing healthcare companies that focus on solving complex problems through technology. Deeply grateful for all the support we have received from Vinay Bansal (Founder & CEO, IPV) and Vikram Ramasubramanian, (Partner, IPV), Arushi Mehta (Investment Manager, IPV) and the entire team.
Another leading investor joining this round is Social Alpha, a venture development platform, dedicated to investing in high-impact, deep tech innovations that have the potential to drive significant social change. Their expertise in the healthcare sector is invaluable as we expand our digital therapeutics offerings. Very grateful to Manoj Kumar (Founder, Social Alpha), Vidya Phalke (Chief Technology Advisor - Social Alpha), Dr. Kshama Kothari (Director, Health - Social Alpha), Manaswini Pai (Manager, Health & Wellness) and the entire team.
Apart from this, we are also grateful to the select group of angel investors including HNIs, CXOs and renowned doctors who have joined this round. Combined, they bring not only capital but also valuable expertise, network and mentorship, helping us further accelerate our vision.
Introducing our Investors
At Wundrsight Health, we are creating the next generation of mental health treatments using immersive, evidence-based digital therapeutics. Our products—such as ReliefXR for stress management, ResistXR for OCD, and ReviveXR for substance use disorders—are designed to improve patient outcomes through virtual reality therapies that complement traditional approaches and can be combined with medicine-based treatments.
Our platform integrates AI and Virtual Reality to provide an immersive, patient-centered experience that enhances therapeutic engagement while reducing over-reliance on medication. We’re also working closely with clinicians to develop comprehensive care management systems that make mental health treatment more evidence-based, personalized and effective.
We are proud to already be partnering with leading hospitals, clinics, and rehabilitation centers in Bangalore and Delhi, where our VR therapy is being integrated as a standard treatment option alongside established methods like ECT, rTMS, and tDCS. What sets us apart is that our solutions offer a non-invasive, side-effect-free alternative with proven results—delivering significantly better treatment outcomes and higher remission rates. This is a game-changer for patients seeking effective, high-quality mental healthcare.
What We’re Doing at Wundrsight
This funding will allow us to:
Expand Product Line: We will further develop and refine our existing suite of VR-based therapeutic solutions and introduce new products addressing neurodevelopmental disorders, neurological disorders and more mental, behavioral health conditions.
Scale Our Hospital Network: We plan to scale up our deployment programs with leading hospitals, clinics and rehab centers, ensuring a wider pan-India reach of our therapeutic products.
Advance Clinical Research: A significant portion of this fundraise will be dedicated to strengthen our evidence-based focus by conducting clinical trials and research to further validate our technology and gain regulatory (FDA, DiGA) approvals for new treatments.
Grow Our Team: We aim to grow our team of clinicians, engineers, and product experts to help us meet the growing demand for our products.
The timing couldn’t be more urgent. There is a global shortage of mental health professionals, with too few clinicians available to meet rising demand. Digital therapeutics are rapidly gaining acceptance as effective, scalable solutions. With regulatory bodies like the FDA, CDSCO, and Germany’s DiGA actively supporting innovation in digital health, we are seeing faster approvals and clearer paths for reimbursement through CPT codes. This, coupled with a growing insurance reimbursement framework, is driving industry growth and encouraging wider adoption of digital therapies.
The market opportunity is immense. In India alone, the mental health sector is expected to grow from USD 6.89 billion in 2023 to an astounding USD 62.86 billion by 2032, with a compound annual growth rate (CAGR) of 28.16%. Globally, these numbers are even more significant, reflecting the urgent need for innovative solutions.
At Wundrsight, we’re building at the right time for this maturing market, with the right team to drive real change.
Why Now
We want to impact the lives of a billion people worldwide by offering accessible and affordable mental healthcare solutions through the use of technology. We want to create a future where mental health care is as accessible and commonplace as physical healthcare, and where everyone has access to the support they need to live happy and healthy lives.
Our Vision for the Future
This milestone wouldn’t be possible without the support of our dedicated team, partners, investors, advisors and the healthcare professionals who believe in us. Your trust and belief in our mission are what drive us forward. A huge shoutout to our earlier backers - Meta, IIT Mandi Catalyst, Dlabs ISB and others without whom we could not have reached this far.
Thank you for being part of Wundrsight’s journey. We’re excited about the future, and we’re just getting started.
Best regards,
Raunak Swarnkar
Co-Founder & CEO, Wundrsight Health
A Heartfelt Thank You
Wundrsight raises USD 400K in Seed Round led by Inflection Point Ventures, Social Alpha and angel investors
12 September, 2024
Dear Wundrsight Community,
It is with great excitement that I announce our successful early-stage fundraise of USD 400,000, led by Inflection Point Ventures, Social Alpha, and a select group of angel investors who share our vision of transforming mental health care. This milestone marks an important step in our journey as we continue to innovate and build solutions that redefine how mental and behavioral healthcare is delivered.
Introducing Our Investors
We are fortunate to have Inflection Point Ventures and Social Alpha as key investors supporting our mission. Inflection Point Ventures has a track record of backing healthcare companies that focus on solving complex problems through technology. Deeply grateful for all the support we have received from Vinay Bansal (Founder & CEO, IPV) and Vikram Ramasubramanian, (Partner, IPV), Arushi Mehta (Investment Manager, IPV) and the entire team.
Another leading investor joining this round is Social Alpha, a venture development platform, dedicated to investing in high-impact, deep tech innovations that have the potential to drive significant social change. Their expertise in the healthcare sector is invaluable as we expand our digital therapeutics offerings. Very grateful to Manoj Kumar (Founder, Social Alpha), Vidya Phalke (Chief Technology Advisor - Social Alpha), Dr. Kshama Kothari (Director, Health - Social Alpha), Manaswini Pai (Manager, Health & Wellness) and the entire team.
Apart from this, we are also grateful to the select group of angel investors including HNIs, CXOs and renowned doctors who have joined this round. Combined, they bring not only capital but also valuable expertise, network and mentorship, helping us further accelerate our vision.
What We’re Doing at Wundrsight
At Wundrsight Health, we are creating the next generation of mental health treatments using immersive, evidence-based digital therapeutics. Our products—such as ReliefXR for stress management, ResistXR for OCD, and ReviveXR for substance use disorders—are designed to improve patient outcomes through virtual reality therapies that complement traditional approaches and can be combined with medicine-based treatments.
Our platform integrates AI and Virtual Reality to provide an immersive, patient-centered experience that enhances therapeutic engagement while reducing over-reliance on medication. We’re also working closely with clinicians to develop comprehensive care management systems that make mental health treatment more evidence-based, personalized and effective.
We are proud to already be partnering with leading hospitals, clinics, and rehabilitation centers in Bangalore and Delhi, where our VR therapy is being integrated as a standard treatment option alongside established methods like ECT, rTMS, and tDCS. What sets us apart is that our solutions offer a non-invasive, side-effect-free alternative with proven results—delivering significantly better treatment outcomes and higher remission rates. This is a game-changer for patients seeking effective, high-quality mental healthcare.
Why We Raised These Funds
This funding will allow us to:
Expand Product Line: We will further develop and refine our existing suite of VR-based therapeutic solutions and introduce new products addressing neurodevelopmental disorders, neurological disorders and more mental, behavioral health conditions.
Scale Our Hospital Network: We plan to scale up our deployment programs with leading hospitals, clinics and rehab centers, ensuring a wider pan-India reach of our therapeutic products.
Advance Clinical Research: A significant portion of this fundraise will be dedicated to strengthen our evidence-based focus by conducting clinical trials and research to further validate our technology and gain regulatory (FDA, DiGA) approvals for new treatments.
Grow Our Team: We aim to grow our team of clinicians, engineers, and product experts to help us meet the growing demand for our products.
Why Now
The timing couldn’t be more urgent. There is a global shortage of mental health professionals, with too few clinicians available to meet rising demand. Digital therapeutics are rapidly gaining acceptance as effective, scalable solutions. With regulatory bodies like the FDA, CDSCO, and Germany’s DiGA actively supporting innovation in digital health, we are seeing faster approvals and clearer paths for reimbursement through CPT codes. This, coupled with a growing insurance reimbursement framework, is driving industry growth and encouraging wider adoption of digital therapies.
The market opportunity is immense. In India alone, the mental health sector is expected to grow from USD 6.89 billion in 2023 to an astounding USD 62.86 billion by 2032, with a compound annual growth rate (CAGR) of 28.16%. Globally, these numbers are even more significant, reflecting the urgent need for innovative solutions.
At Wundrsight, we’re building at the right time for this maturing market, with the right team to drive real change.
A Heartfelt Thank You
This milestone wouldn’t be possible without the support of our dedicated team, partners, investors, advisors and the healthcare professionals who believe in us. Your trust and belief in our mission are what drive us forward. A huge shoutout to our earlier backers - Meta, IIT Mandi Catalyst, Dlabs ISB and others without whom we could not have reached this far.
Thank you for being part of Wundrsight’s journey. We’re excited about the future, and we’re just getting started.
Best regards,
Raunak Swarnkar
Co-Founder & CEO, Wundrsight Health
Why We Raised These Funds
Home
Products
Hospitals and Clinics
Blogs
About Us
Contact Us
Home
Products
Hospitals and Clinics
Blogs
About Us
Contact Us
Our Vision for the Future
We want to impact the lives of a billion people worldwide by offering accessible and affordable mental healthcare solutions through the use of technology. We want to create a future where mental health care is as accessible and commonplace as physical healthcare, and where everyone has access to the support they need to live happy and healthy lives.
Copyright © 2024. All rights reserved